Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1971 1
1973 1
1975 1
1976 1
1977 1
1979 2
1981 1
1982 2
1983 2
1984 4
1986 1
1987 2
1988 3
1989 4
1990 3
1991 2
1992 2
1995 3
1997 1
1998 4
1999 6
2000 3
2001 4
2002 2
2003 3
2004 6
2005 10
2006 6
2007 13
2008 10
2009 8
2010 12
2011 10
2012 12
2013 6
2014 16
2015 26
2016 21
2017 14
2018 13
2019 22
2020 24
2021 37
2022 41
2023 30
2024 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

417 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic Induction of Trained Immunity through the Mevalonate Pathway.
Bekkering S, Arts RJW, Novakovic B, Kourtzelis I, van der Heijden CDCC, Li Y, Popa CD, Ter Horst R, van Tuijl J, Netea-Maier RT, van de Veerdonk FL, Chavakis T, Joosten LAB, van der Meer JWM, Stunnenberg H, Riksen NP, Netea MG. Bekkering S, et al. Among authors: popa cd. Cell. 2018 Jan 11;172(1-2):135-146.e9. doi: 10.1016/j.cell.2017.11.025. Cell. 2018. PMID: 29328908 Free article.
Brain-heart axis--Review Article.
Manea MM, Comsa M, Minca A, Dragos D, Popa C. Manea MM, et al. Among authors: popa c. J Med Life. 2015 Jul-Sep;8(3):266-71. J Med Life. 2015. PMID: 26351525 Free PMC article. Review.
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
Pérez-García JM, Cortés J, Ruiz-Borrego M, Colleoni M, Stradella A, Bermejo B, Dalenc F, Escrivá-de-Romaní S, Calvo Martínez L, Ribelles N, Marmé F, Cortés A, Albacar C, Gebhart G, Prat A, Kerrou K, Schmid P, Braga S, Di Cosimo S, Gion M, Antonarelli G, Popa C, Szostak E, Alcalá-López D, Gener P, Rodríguez-Morató J, Mina L, Sampayo-Cordero M, Llombart-Cussac A; PHERGain Trial Investigators. Pérez-García JM, et al. Among authors: popa c. Lancet. 2024 Apr 27;403(10437):1649-1659. doi: 10.1016/S0140-6736(24)00054-0. Epub 2024 Apr 3. Lancet. 2024. PMID: 38582092 Clinical Trial.
Acetaminophen Exacerbates Hypertension: A #NephJC Editorial on PATH-BP.
John P, Popa C, Abbasi M, Teakell J, Hiremath S, Willows J. John P, et al. Among authors: popa c. Kidney Med. 2022 Jun 28;4(8):100515. doi: 10.1016/j.xkme.2022.100515. eCollection 2022 Aug. Kidney Med. 2022. PMID: 35942504 Free PMC article. No abstract available.
Clinical Images: Cholesterol crystals bursitis.
Popa CD, Martens HA. Popa CD, et al. ACR Open Rheumatol. 2023 Jun;5(6):287. doi: 10.1002/acr2.11542. Epub 2023 Apr 4. ACR Open Rheumatol. 2023. PMID: 37015853 Free PMC article. No abstract available.
417 results